Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Approves Edwards’ Sapien 3 With The Alterra Prestent For Pulmonary Regurgitation

Dec 20 2021

• By Reed Miller

Related Content

Edwards Stays On Track For ‘Mid-Teens’ TAVR Growth In 2021

Apr 27 2021

FDA Approves Two New Indications For Edwards’ Sapien 3 TAVR System

Sep 14 2020

Related Companies

Edwards Lifesciences Corp.

Additional Topics

Approvals Clinical Trials Innovation Cardiovascular Cardiology Medical Device

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window